Soverini, S http://orcid.org/0000-0002-4508-0353
De Benedittis, C
Papayannidis, C
Polakova, K Machova
Venturi, C
Russo, D
Bresciani, P
Iurlo, A
Mancini, M
Vitale, A
Chiaretti, S
Foà, R
Abruzzese, E
Sorà, F
Kohlmann, A
Haferlach, T
Baccarani, M
Cavo, M
Martinelli, G
Article History
First Online: 12 February 2016
Competing interests
: SS served as a consultant for Novartis, Bristol-Myers Squibb and Ariad; KMP received research funding and honoraria from Novartis and Bristol-Myers Squibb; AK was a former employee of the Munich Leukemia Laboratory (MLL), is now an employee of Astra Zeneca, UK, and has received honoraria from Roche diagnostics; TH is part owner of the MLL; MB and GM served as consultants for and received honoraria from Novartis, Bristol-Myers Squibb, Ariad and Pfizer. The remaining authors declare no conflict of interest.